# IgniteData

> IgniteData is a healthtech company automating the transfer of clinical trial data between hospital electronic health records (EHRs) and sponsors' electronic data capture (EDC) systems. Its flagship platform, Archer, is a cloud-based, system-agnostic 'Virtual Research Assistant' that uses HL7 FHIR and SMART on FHIR APIs to move clinically validated data securely and automatically, cutting manual transcription, reducing source data verification, and helping treatments reach patients faster. Founded in the UK and now operating on both sides of the Atlantic, IgniteData works with pharmaceutical sponsors like AstraZeneca and research hospitals including UCLH, Cambridge University Hospitals, and Memorial Sloan Kettering Cancer Center.

- **Founded:** 2013
- **Headquarters:** Maidenhead, Berkshire, United Kingdom (US office: Wilmington, Delaware)
- **Founders:** Dan Hydes (Co-founder & President (formerly CEO)), Richard Yeatman (Co-founder & COO (formerly CTO))
- **Team size:** ~51 employees
- **Products:** Archer
- **Notable:** Built what it describes as the world's first truly agnostic EHR-to-EDC system (Archer)., Won over £1 million in UK Government grants to develop Archer., Live pilot mapped and transferred 100% of Vital Signs and Labs data in an AstraZeneca Phase 3 oncology study at UCLH.

## Products & services

- **Archer** — A cloud-based, system-agnostic 'Virtual Research Assistant' that automates EHR-to-EDC data transfer. It uses HL7 FHIR and SMART on FHIR APIs to move clinically validated data directly from a hospital's electronic health record into a sponsor's electronic data capture system or other research application, with a regulatory-grade mapping engine, audit trail, and the clinician retaining control of transfers.

## Achievements

- Built what it describes as the world's first truly agnostic EHR-to-EDC system (Archer).
- Won over £1 million in UK Government grants to develop Archer.
- Live pilot mapped and transferred 100% of Vital Signs and Labs data in an AstraZeneca Phase 3 oncology study at UCLH.
- Archer shortlisted by the EHR2EDC Consortium (led by AstraZeneca, Janssen and Sanofi).
- Deployed at leading research hospitals including UCLH, Cambridge University Hospitals and Memorial Sloan Kettering.
- Raised a Series A led by FCA Venture Partners (August 2025) to fund global expansion.

## Latest updates

- **2025-08** — Raised a Series A round led by FCA Venture Partners, with returning investors SpringTide and Oncology Ventures, to accelerate global site-network expansion and clinical trial data automation.
- **2025-03** — Launched Archer data integration platform for clinical trials at Cambridge University Hospitals with AstraZeneca.
- **2025-04** — Announced successful deployment of Archer at a leading cancer center (Memorial Sloan Kettering).
- **2025-01** — Announced partnership with Advarra to streamline eSource-to-EDC data transfer for research sites.

## Links

- Website: https://ignitedata.com
- LinkedIn: https://www.linkedin.com/company/ignite-data
- Twitter/X: https://twitter.com/ignitedata

---

Profile page: https://yespress.io/ignitedata
Published by YesPress — https://yespress.io
Last updated: 2026-07-20